InvestorsHub Logo
Followers 0
Posts 25
Boards Moderated 0
Alias Born 03/27/2013

Re: zz1 post# 3683

Tuesday, 04/02/2013 9:21:50 AM

Tuesday, April 02, 2013 9:21:50 AM

Post# of 425933
Vascepa lowers TG,CRP.FDA label does not mention CRP.Have you seen the booklet sent to physicians?No mention of lowering CRP.
Majority of physicians do not know that Epadel has been used in Japan for over 23 years--and large study JELIS proved its effectiveness.Mochida sales in Japan were over 500 mil.$/year from Epadel.
In medical community--if one doctor tries a new medicine in one area--others hear about it and get on the bandwagon.I think Amarin should communicate with Internal medicine/Family practitioners aggressively.I got my prescription from an Internal med.doctor.These doctors do blood test as part of Preventative Health Checkup.If TG is high--they look at options.First option is diet and exercise--next option is Statins like Lipitor, 3rd option is Lovaza as they have experience with Lovaza.Most of these doctors have NOT heard of VASCEPA. No Sales Rep. has visited my doctor's group yet.
Well known Cardiologists told me that me that they await REDUCE-IT study--as they saw the results of ORIGIN study for FISH OIL. These docs have reservations about JELIS-- for not having saved lives.
Could you please find out when to expect early results from Reduce-IT ? Jupiter trials results --selected the patients carefully with high C-RP showed dramatic results in 2009--in 2nd year.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News